INS and Hyperglycemia: The frequent hyperglycemia reported here, the known on-target effect of PI3Kα inhibition as mediating insulin signaling,44 was expectedly higher than several PI3Kδ inhibitors.12,32,43 However, hyperglycemia was mostly grade 1–2 and controllable using dose modification or supportive care.